Concordance to National Comprehensive Cancer Network (NCCN) clinical practice guideline (GL) drug therapy recommendations for metastatic breast cancer: An analysis from the commercial managed care claims database PharMetrics (PM).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 1032-1032
Author(s):  
E. M. Lepisto ◽  
K. Tangirala ◽  
J. L. Vandergrift ◽  
J. S. McClure ◽  
D. L. McNally ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Clinical Practice ◽  
Drug Therapy ◽  
National Comprehensive Cancer Network ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Metastatic Breast ◽  
Claims Database ◽  
Cancer Network

scholarly journals American Society of Clinical Oncology Clinical Practice Guideline Update: Recommendations on the Role of Bone-Modifying Agents in Metastatic Breast Cancer

2011 ◽  
Vol 7 (2) ◽  
pp. 117-121 ◽  
Author(s):  
Catherine H. Van Poznak ◽  
Jamie H. Von Roenn ◽  
Sarah Temin
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Clinical Practice ◽  
Bone Metastases ◽  
Clinical Oncology ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Metastatic Breast ◽  
American Society

Journal of Clinical Oncology recently published ASCO's update to its guideline on the use of bone-modifying agents for patients with bone metastases, the scope of which was narrowed to the use of bone-modifying agents for patients with evidence of bone metastases.

Sign in / Sign up

Export Citation Format

Share Document